EVOCICLIB 125

Capsule — 125 mg

verifiedWHO-GMP

descriptionProduct Overview

Palbociclib capsules are a targeted kinase inhibitor therapy used to treat hormone receptor-positive. HER2-negative advanced or metastatic breast cancer.

healingIndications

Palbociclib capsules are indicated for treating HR-positive, HER2-negative advanced or metastatic breast cancer.

medical_servicesDosage Forms & Strength

Available Forms

Capsule

Strength

125 mg

assignment_turned_inRegulatory Approvals

check_circleWHO-GMP